Retrospective Analysis of Risk Factors for Cefoperazone/Sulbactam-Induced Thrombocytopenia in Adult Chinese Patients: A Six-Year Real-World Study
Despite the low incidence (2.4%), cefoperazone/sulbactam could cause serious thrombocytopenia sometimes accompanied with hemorrhage. In clinical therapy, clinicians should be vigilant in monitoring platelet count, especially for patients with risk factors of cefoperazone/sulbactam-induced thrombocytopenia.
Authors
- Bolin Zhu (ORCID: https://orcid.org/0000-0002-6846-566X)
- Pengfei Jin (ORCID: https://orcid.org/0000-0002-8908-2633)
- Jianchun Li (ORCID: https://orcid.org/0000-0001-6550-8540)
- Yuanchao Zhu (ORCID: https://orcid.org/0000-0001-5646-3379)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/idr.s475590
- Citations
- 4
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.82